SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5cwa'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_A_BEZA1501_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	6 / 11	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388 LEU A 416	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) 0GA A 604 ( 4.7A)	0.67A	1i7qA-5cwaA: 41.2	1i7qA-5cwaA: 38.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_A_BEZA1501_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 ILE A 322 THR A 325 HIS A 388 GLY A 474	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) 0GA A 604 ( 4.4A)	1.00A	1i7qA-5cwaA: 41.2	1i7qA-5cwaA: 38.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_A_BEZA1501_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	6 / 11	GLU A 307 ILE A 322 THR A 325 HIS A 388 LEU A 416 GLY A 475	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) 0GA A 604 ( 4.7A) None	0.79A	1i7qA-5cwaA: 41.2	1i7qA-5cwaA: 38.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_A_BEZA1501_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 LEU A 416 GLY A 475 GLU A 488 LYS A 492	0GA A 604 ( 4.5A) 0GA A 604 ( 4.7A) None 0GA A 604 ( 4.9A) 0GA A 604 (-3.0A)	0.80A	1i7qA-5cwaA: 41.2	1i7qA-5cwaA: 38.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_C_BEZC1502_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	6 / 10	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388 GLY A 475	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) None	0.68A	1i7qC-5cwaA: 41.2	1i7qC-5cwaA: 38.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Q_C_BEZC1502_0 (ANTHRANILATE SYNTHASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 10	GLU A 307 ILE A 322 THR A 325 HIS A 388 GLY A 474	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) 0GA A 604 ( 4.4A)	0.95A	1i7qC-5cwaA: 41.2	1i7qC-5cwaA: 38.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1IBG_H_OBNH1_2 (IGG2B-KAPPA 40-50 FAB (HEAVY CHAIN) IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN))	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 7	THR A 216 SER A 215 TYR A 273 LEU A 53	None	1.11A	1ibgL-5cwaA: 2.5	1ibgL-5cwaA: 17.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	SER A 304 ARG A 459 ASN A 280 TRP A 63	None SO4 A 601 (-3.6A) SO4 A 601 ( 4.8A) None	1.26A	1rs6A-5cwaA: undetectable	1rs6A-5cwaA: 21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	SER A 304 ARG A 459 ASN A 280 TRP A 63	None SO4 A 601 (-3.6A) SO4 A 601 ( 4.8A) None	1.20A	1rs6B-5cwaA: undetectable	1rs6B-5cwaA: 21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS7_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	SER A 304 ARG A 459 ASN A 280 TRP A 63	None SO4 A 601 (-3.6A) SO4 A 601 ( 4.8A) None	1.25A	1rs7B-5cwaA: undetectable	1rs7B-5cwaA: 21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Z9H_A_IMNA379_1 (MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	VAL A 138 TYR A 135 ILE A 428 VAL A 422 LEU A 144	None	1.41A	1z9hA-5cwaA: undetectable	1z9hA-5cwaA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Z9H_B_IMNB381_1 (MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	VAL A 138 TYR A 135 ILE A 428 VAL A 422 LEU A 144	None	1.41A	1z9hB-5cwaA: undetectable	1z9hB-5cwaA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Z9H_C_IMNC379_1 (MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	VAL A 138 TYR A 135 ILE A 428 VAL A 422 LEU A 144	None	1.41A	1z9hC-5cwaA: undetectable	1z9hC-5cwaA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AZQ_A_PCFA954_0 (CATECHOL 1,2-DIOXYGENASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	LEU A 358 GLU A 307 HIS A 388 ALA A 323 GLU A 488	None 0GA A 604 ( 4.5A) 0GA A 604 ( 4.3A) None 0GA A 604 ( 4.9A)	1.40A	2azqA-5cwaA: undetectable	2azqA-5cwaA: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXQ_A_IMNA2001_1 (SERUM ALBUMIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 10	ALA A 134 PHE A 133 LEU A 77 LEU A 104 LEU A 438	None None None None GOL A 605 (-3.9A)	1.06A	2bxqA-5cwaA: undetectable	2bxqA-5cwaA: 21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FN1_A_SALA506_1 (SALICYLATE SYNTHETASE, IRP9)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 GLY A 324 THR A 325 HIS A 388 GLY A 475	0GA A 604 ( 4.5A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) None	0.72A	2fn1A-5cwaA: 38.4	2fn1A-5cwaA: 28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FN1_B_SALB503_1 (SALICYLATE SYNTHETASE, IRP9)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 GLY A 324 THR A 325 HIS A 388 THR A 415	0GA A 604 ( 4.5A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) None	0.56A	2fn1B-5cwaA: 38.1	2fn1B-5cwaA: 28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FN1_B_SALB503_1 (SALICYLATE SYNTHETASE, IRP9)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 THR A 325 HIS A 388 THR A 415 GLY A 474	0GA A 604 ( 4.5A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) None 0GA A 604 ( 4.4A)	0.95A	2fn1B-5cwaA: 38.1	2fn1B-5cwaA: 28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FN1_B_SALB503_1 (SALICYLATE SYNTHETASE, IRP9)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 THR A 325 HIS A 388 THR A 415 GLY A 475	0GA A 604 ( 4.5A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A) None None	0.54A	2fn1B-5cwaA: 38.1	2fn1B-5cwaA: 28.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V32_D_BEZD1221_0 (PEROXIREDOXIN 6)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	VAL A 256 PRO A 257 VAL A 477 SER A 480	None	0.96A	2v32C-5cwaA: undetectable 2v32D-5cwaA: undetectable	2v32C-5cwaA: 18.13 2v32D-5cwaA: 18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_C_X2NC1479_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	PHE A 454 VAL A 442 ALA A 162 THR A 107 LEU A 104	None	1.27A	2x2nC-5cwaA: undetectable	2x2nC-5cwaA: 23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BXO_A_SAMA238_1 (N,N-DIMETHYLTRANSFER ASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	3 / 3	TYR A 439 GLU A 485 ASP A 479	0GA A 604 ( 4.4A) None None	0.84A	3bxoA-5cwaA: undetectable	3bxoA-5cwaA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3C6G_B_VD3B700_1 (CYTOCHROME P450 2R1)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	LEU A 287 ALA A 499 VAL A 496 GLY A 303 VAL A 297	None	1.07A	3c6gB-5cwaA: undetectable	3c6gB-5cwaA: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CYX_A_ROCA201_1 (HIV-1 PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.04A	3cyxA-5cwaA: undetectable	3cyxA-5cwaA: 11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D1Z_B_017B201_2 (HIV-1 PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.06A	3d1zB-5cwaA: undetectable	3d1zB-5cwaA: 10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DH0_A_SAMA220_1 (SAM DEPENDENT METHYLTRANSFERASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	ARG A 464 TYR A 469 ASP A 136 GLU A 146	None	1.25A	3dh0A-5cwaA: undetectable	3dh0A-5cwaA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DL9_A_V2HA602_1 (CYTOCHROME P450 2R1)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 5	ALA A 166 LEU A 125 GLY A 127 THR A 75	None	0.87A	3dl9A-5cwaA: undetectable	3dl9A-5cwaA: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EBZ_B_017B201_2 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.06A	3ebzB-5cwaA: undetectable	3ebzB-5cwaA: 12.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_B_017B200_1 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.05A	3ektA-5cwaA: undetectable	3ektA-5cwaA: 11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_D_017D200_2 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.06A	3ektD-5cwaA: undetectable	3ektD-5cwaA: 11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R75_A_BEZA701_0 (ANTHRANILATE/PARA-AM INOBENZOATE SYNTHASES COMPONENT I)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	0.27A	3r75A-5cwaA: 34.5	3r75A-5cwaA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R75_B_BEZB701_0 (ANTHRANILATE/PARA-AM INOBENZOATE SYNTHASES COMPONENT I)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	0.29A	3r75B-5cwaA: 33.8	3r75B-5cwaA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R76_A_BEZA701_0 (ANTHRANILATE/PARA-AM INOBENZOATE SYNTHASES COMPONENT I)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	0.27A	3r76A-5cwaA: 34.8	3r76A-5cwaA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R76_B_BEZB701_0 (ANTHRANILATE/PARA-AM INOBENZOATE SYNTHASES COMPONENT I)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 11	GLU A 307 ILE A 322 GLY A 324 THR A 325 HIS A 388	0GA A 604 ( 4.5A) 0GA A 604 ( 4.2A) None 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	0.29A	3r76B-5cwaA: 33.9	3r76B-5cwaA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UCB_A_017A201_1 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.04A	3ucbA-5cwaA: undetectable	3ucbA-5cwaA: 11.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WSJ_A_MK1A201_1 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	LEU A 177 ALA A 32 ASP A 33 VAL A 168 ILE A 175	None	0.96A	3wsjA-5cwaA: undetectable	3wsjA-5cwaA: 13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_1 (WBDD)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 6	ARG A 464 ASP A 156 GLU A 146 LEU A 152	None None None GOL A 605 (-4.7A)	1.41A	4ax8A-5cwaA: 2.5	4ax8A-5cwaA: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGK_A_0TXA302_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 7	GLY A 474 GLY A 473 TYR A 439 GLU A 485	0GA A 604 ( 4.4A) 0GA A 604 (-3.8A) 0GA A 604 ( 4.4A) None	1.08A	4fgkB-5cwaA: undetectable	4fgkB-5cwaA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_A_CQAA302_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 7	GLU A 426 GLU A 429 ARG A 436 GLY A 418	None	1.02A	4fgzA-5cwaA: undetectable	4fgzA-5cwaA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_1 (METHYLTRANSFERASE NSUN4)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	3 / 3	ASP A 298 ARG A 464 ASP A 294	None	0.53A	4fp9C-5cwaA: undetectable	4fp9C-5cwaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_1 (METHYLTRANSFERASE NSUN4)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	3 / 3	ASP A 298 ARG A 464 ASP A 294	None	0.53A	4fp9F-5cwaA: undetectable	4fp9F-5cwaA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_D_017D101_2 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.10A	4njtD-5cwaA: undetectable	4njtD-5cwaA: 11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R7I_A_STIA1001_2 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 5	LEU A 427 VAL A 477 TYR A 242 ARG A 459	None None None SO4 A 601 (-3.6A)	1.04A	4r7iA-5cwaA: undetectable	4r7iA-5cwaA: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XDT_A_ACTA407_0 (FAD:PROTEIN FMN TRANSFERASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	3 / 3	ASP A 115 GLY A 450 ASP A 447	None	0.62A	4xdtA-5cwaA: 0.5	4xdtA-5cwaA: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP1_A_LDPA708_1 (DOPAMINE TRANSPORTER, ISOFORM B)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 10	ALA A 461 VAL A 496 SER A 305 SER A 304 GLY A 303	None	1.12A	4xp1A-5cwaA: undetectable	4xp1A-5cwaA: 22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YDQ_A_HFGA802_1 (PROLINE--TRNA LIGASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 4	THR A 415 GLU A 307 THR A 325 HIS A 388	None 0GA A 604 ( 4.5A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	1.47A	4ydqA-5cwaA: undetectable	4ydqA-5cwaA: 19.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z90_F_4LEF401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 8	LEU A 159 THR A 107 LEU A 108 LEU A 104	None	0.78A	4z90F-5cwaA: undetectable 4z90G-5cwaA: undetectable 4z90H-5cwaA: undetectable 4z90I-5cwaA: undetectable 4z90J-5cwaA: undetectable	4z90F-5cwaA: 21.07 4z90G-5cwaA: 21.07 4z90H-5cwaA: 21.07 4z90I-5cwaA: 21.07 4z90J-5cwaA: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0Y_A_FOLA201_0 (CONSERVED HYPOTHETICAL MEMBRANE PROTEIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	GLY A 70 ASP A 447 PHE A 448 ASN A 180 VAL A 182	None	1.26A	5d0yA-5cwaA: undetectable	5d0yA-5cwaA: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECK_A_ILEA601_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 6	ALA A 162 THR A 163 VAL A 165 VAL A 23	None	0.95A	5eckA-5cwaA: undetectable	5eckA-5cwaA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ECK_D_ILED601_0 (JASMONIC ACID-AMIDO SYNTHETASE JAR1)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 6	ALA A 162 THR A 163 VAL A 165 VAL A 23	None	0.87A	5eckD-5cwaA: undetectable	5eckD-5cwaA: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F9Z_A_HFGA702_1 (AMINOACYL-TRNA SYNTHETASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 4	THR A 415 GLU A 307 THR A 325 HIS A 388	None 0GA A 604 ( 4.5A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	1.43A	5f9zA-5cwaA: undetectable	5f9zA-5cwaA: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5F9Z_B_HFGB703_1 (AMINOACYL-TRNA SYNTHETASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	4 / 4	THR A 415 GLU A 307 THR A 325 HIS A 388	None 0GA A 604 ( 4.5A) 0GA A 604 ( 4.6A) 0GA A 604 ( 4.3A)	1.43A	5f9zB-5cwaA: undetectable	5f9zB-5cwaA: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_B_SAMB501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	6 / 9	ARG A 201 ILE A 69 GLY A 70 GLY A 72 LEU A 209 LEU A 177	None	1.21A	5o96A-5cwaA: undetectable 5o96B-5cwaA: undetectable	5o96A-5cwaA: 20.04 5o96B-5cwaA: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T2Z_B_017B201_1 (PROTEASE)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 12	LEU A 125 ASP A 447 GLY A 450 ALA A 449 ASP A 115	None	1.08A	5t2zA-5cwaA: undetectable	5t2zA-5cwaA: 12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AWO_A_SREA701_1 (SODIUM-DEPENDENT SEROTONIN TRANSPORTER)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	ALA A 457 ILE A 456 GLY A 474 SER A 417 GLY A 440	None None 0GA A 604 ( 4.4A) None None	1.29A	6awoA-5cwaA: undetectable	6awoA-5cwaA: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AWQ_A_SREA701_1 (SODIUM-DEPENDENT SEROTONIN TRANSPORTER)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 9	ALA A 457 ILE A 456 GLY A 474 SER A 417 GLY A 440	None None 0GA A 604 ( 4.4A) None None	1.29A	6awqA-5cwaA: undetectable	6awqA-5cwaA: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D8F_A_ACTA803_0 (UNCHARACTERIZED PROTEIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	3 / 3	GLU A 339 LEU A 342 ARG A 349	None	0.77A	6d8fA-5cwaA: undetectable	6d8fA-5cwaA: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F6N_A_SREA508_1 (ENVELOPE GLYCOPROTEIN,ENVELOP E GLYCOPROTEIN,GP1 ENVELOPE GLYCOPROTEIN)	5cwa	ANTHRANILATE SYNTHASE COMPONENT 1 (Mycobacterium tuberculosis)	5 / 10	ARG A 22 VAL A 182 LEU A 111 LEU A 77 LEU A 161	None	1.00A	6f6nA-5cwaA: undetectable 6f6nB-5cwaA: undetectable	6f6nA-5cwaA: 10.83 6f6nB-5cwaA: 9.09

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1I7Q_A_BEZA1501_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",6,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388;LEU A 416","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);0GA A 604 ( 4.7A)","0.67A","1i7qA-5cwaA:41.2","1i7qA-5cwaA:38.38"],["1I7Q_A_BEZA1501_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;THR A 325;HIS A 388;GLY A 474","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);0GA A 604 ( 4.4A)","1.00A","1i7qA-5cwaA:41.2","1i7qA-5cwaA:38.38"],["1I7Q_A_BEZA1501_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",6,"GLU A 307;ILE A 322;THR A 325;HIS A 388;LEU A 416;GLY A 475","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);0GA A 604 ( 4.7A);None","0.79A","1i7qA-5cwaA:41.2","1i7qA-5cwaA:38.38"],["1I7Q_A_BEZA1501_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;LEU A 416;GLY A 475;GLU A 488;LYS A 492","0GA A 604 ( 4.5A);0GA A 604 ( 4.7A);None;0GA A 604 ( 4.9A);0GA A 604 (-3.0A)","0.80A","1i7qA-5cwaA:41.2","1i7qA-5cwaA:38.38"],["1I7Q_C_BEZC1502_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",6,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388;GLY A 475","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);None","0.68A","1i7qC-5cwaA:41.2","1i7qC-5cwaA:38.38"],["1I7Q_C_BEZC1502_0","ANTHRANILATE SYNTHASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;THR A 325;HIS A 388;GLY A 474","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);0GA A 604 ( 4.4A)","0.95A","1i7qC-5cwaA:41.2","1i7qC-5cwaA:38.38"],["1IBG_H_OBNH1_2","IGG2B-KAPPA 40-50 FAB (HEAVY CHAIN);IGG2B-KAPPA 40-50 FAB (LIGHT CHAIN)","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"THR A 216;SER A 215;TYR A 273;LEU A  53","None","1.11A","1ibgL-5cwaA:2.5","1ibgL-5cwaA:17.21"],["1RS6_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"SER A 304;ARG A 459;ASN A 280;TRP A  63","None;SO4 A 601 (-3.6A);SO4 A 601 ( 4.8A);None","1.26A","1rs6A-5cwaA:undetectable","1rs6A-5cwaA:21.60"],["1RS6_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"SER A 304;ARG A 459;ASN A 280;TRP A  63","None;SO4 A 601 (-3.6A);SO4 A 601 ( 4.8A);None","1.20A","1rs6B-5cwaA:undetectable","1rs6B-5cwaA:21.60"],["1RS7_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"SER A 304;ARG A 459;ASN A 280;TRP A  63","None;SO4 A 601 (-3.6A);SO4 A 601 ( 4.8A);None","1.25A","1rs7B-5cwaA:undetectable","1rs7B-5cwaA:21.60"],["1Z9H_A_IMNA379_1","MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"VAL A 138;TYR A 135;ILE A 428;VAL A 422;LEU A 144","None","1.41A","1z9hA-5cwaA:undetectable","1z9hA-5cwaA:20.98"],["1Z9H_B_IMNB381_1","MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"VAL A 138;TYR A 135;ILE A 428;VAL A 422;LEU A 144","None","1.41A","1z9hB-5cwaA:undetectable","1z9hB-5cwaA:20.98"],["1Z9H_C_IMNC379_1","MEMBRANE-ASSOCIATED PROSTAGLANDIN E SYNTHASE-2","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"VAL A 138;TYR A 135;ILE A 428;VAL A 422;LEU A 144","None","1.41A","1z9hC-5cwaA:undetectable","1z9hC-5cwaA:20.98"],["2AZQ_A_PCFA954_0","CATECHOL 1,2-DIOXYGENASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 358;GLU A 307;HIS A 388;ALA A 323;GLU A 488","None;0GA A 604 ( 4.5A);0GA A 604 ( 4.3A);None;0GA A 604 ( 4.9A)","1.40A","2azqA-5cwaA:undetectable","2azqA-5cwaA:22.57"],["2BXQ_A_IMNA2001_1","SERUM ALBUMIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"ALA A 134;PHE A 133;LEU A  77;LEU A 104;LEU A 438","None;None;None;None;GOL A 605 (-3.9A)","1.06A","2bxqA-5cwaA:undetectable","2bxqA-5cwaA:21.82"],["2FN1_A_SALA506_1","SALICYLATE SYNTHETASE, IRP9","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;GLY A 324;THR A 325;HIS A 388;GLY A 475","0GA A 604 ( 4.5A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);None","0.72A","2fn1A-5cwaA:38.4","2fn1A-5cwaA:28.40"],["2FN1_B_SALB503_1","SALICYLATE SYNTHETASE, IRP9","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;GLY A 324;THR A 325;HIS A 388;THR A 415","0GA A 604 ( 4.5A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);None","0.56A","2fn1B-5cwaA:38.1","2fn1B-5cwaA:28.40"],["2FN1_B_SALB503_1","SALICYLATE SYNTHETASE, IRP9","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;THR A 325;HIS A 388;THR A 415;GLY A 474","0GA A 604 ( 4.5A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);None;0GA A 604 ( 4.4A)","0.95A","2fn1B-5cwaA:38.1","2fn1B-5cwaA:28.40"],["2FN1_B_SALB503_1","SALICYLATE SYNTHETASE, IRP9","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;THR A 325;HIS A 388;THR A 415;GLY A 475","0GA A 604 ( 4.5A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A);None;None","0.54A","2fn1B-5cwaA:38.1","2fn1B-5cwaA:28.40"],["2V32_D_BEZD1221_0","PEROXIREDOXIN 6","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"VAL A 256;PRO A 257;VAL A 477;SER A 480","None","0.96A","2v32C-5cwaA:undetectable;2v32D-5cwaA:undetectable","2v32C-5cwaA:18.13;2v32D-5cwaA:18.13"],["2X2N_C_X2NC1479_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"PHE A 454;VAL A 442;ALA A 162;THR A 107;LEU A 104","None","1.27A","2x2nC-5cwaA:undetectable","2x2nC-5cwaA:23.41"],["3BXO_A_SAMA238_1","N,N-DIMETHYLTRANSFERASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",3,"TYR A 439;GLU A 485;ASP A 479","0GA A 604 ( 4.4A);None;None","0.84A","3bxoA-5cwaA:undetectable","3bxoA-5cwaA:20.93"],["3C6G_B_VD3B700_1","CYTOCHROME P450 2R1","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 287;ALA A 499;VAL A 496;GLY A 303;VAL A 297","None","1.07A","3c6gB-5cwaA:undetectable","3c6gB-5cwaA:20.65"],["3CYX_A_ROCA201_1","HIV-1 PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.04A","3cyxA-5cwaA:undetectable","3cyxA-5cwaA:11.18"],["3D1Z_B_017B201_2","HIV-1 PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.06A","3d1zB-5cwaA:undetectable","3d1zB-5cwaA:10.59"],["3DH0_A_SAMA220_1","SAM DEPENDENT METHYLTRANSFERASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"ARG A 464;TYR A 469;ASP A 136;GLU A 146","None","1.25A","3dh0A-5cwaA:undetectable","3dh0A-5cwaA:19.26"],["3DL9_A_V2HA602_1","CYTOCHROME P450 2R1","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"ALA A 166;LEU A 125;GLY A 127;THR A  75","None","0.87A","3dl9A-5cwaA:undetectable","3dl9A-5cwaA:20.65"],["3EBZ_B_017B201_2","PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.06A","3ebzB-5cwaA:undetectable","3ebzB-5cwaA:12.60"],["3EKT_B_017B200_1","PROTEASE;PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.05A","3ektA-5cwaA:undetectable","3ektA-5cwaA:11.16"],["3EKT_D_017D200_2","PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.06A","3ektD-5cwaA:undetectable","3ektD-5cwaA:11.16"],["3R75_A_BEZA701_0","ANTHRANILATE\/PARA-AMINOBENZOATE SYNTHASES COMPONENT I","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","0.27A","3r75A-5cwaA:34.5","3r75A-5cwaA:24.10"],["3R75_B_BEZB701_0","ANTHRANILATE\/PARA-AMINOBENZOATE SYNTHASES COMPONENT I","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","0.29A","3r75B-5cwaA:33.8","3r75B-5cwaA:24.10"],["3R76_A_BEZA701_0","ANTHRANILATE\/PARA-AMINOBENZOATE SYNTHASES COMPONENT I","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","0.27A","3r76A-5cwaA:34.8","3r76A-5cwaA:24.10"],["3R76_B_BEZB701_0","ANTHRANILATE\/PARA-AMINOBENZOATE SYNTHASES COMPONENT I","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLU A 307;ILE A 322;GLY A 324;THR A 325;HIS A 388","0GA A 604 ( 4.5A);0GA A 604 ( 4.2A);None;0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","0.29A","3r76B-5cwaA:33.9","3r76B-5cwaA:24.10"],["3UCB_A_017A201_1","PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.04A","3ucbA-5cwaA:undetectable","3ucbA-5cwaA:11.53"],["3WSJ_A_MK1A201_1","PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 177;ALA A  32;ASP A  33;VAL A 168;ILE A 175","None","0.96A","3wsjA-5cwaA:undetectable","3wsjA-5cwaA:13.20"],["4AX8_A_SAMA1474_1","WBDD","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"ARG A 464;ASP A 156;GLU A 146;LEU A 152","None;None;None;GOL A 605 (-4.7A)","1.41A","4ax8A-5cwaA:2.5","4ax8A-5cwaA:21.43"],["4FGK_A_0TXA302_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"GLY A 474;GLY A 473;TYR A 439;GLU A 485","0GA A 604 ( 4.4A);0GA A 604 (-3.8A);0GA A 604 ( 4.4A);None","1.08A","4fgkB-5cwaA:undetectable","4fgkB-5cwaA:19.88"],["4FGZ_A_CQAA302_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"GLU A 426;GLU A 429;ARG A 436;GLY A 418","None","1.02A","4fgzA-5cwaA:undetectable","4fgzA-5cwaA:18.37"],["4FP9_C_SAMC401_1","METHYLTRANSFERASE NSUN4","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",3,"ASP A 298;ARG A 464;ASP A 294","None","0.53A","4fp9C-5cwaA:undetectable","4fp9C-5cwaA:22.48"],["4FP9_F_SAMF401_1","METHYLTRANSFERASE NSUN4","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",3,"ASP A 298;ARG A 464;ASP A 294","None","0.53A","4fp9F-5cwaA:undetectable","4fp9F-5cwaA:22.48"],["4NJT_D_017D101_2","PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.10A","4njtD-5cwaA:undetectable","4njtD-5cwaA:11.18"],["4R7I_A_STIA1001_2","MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"LEU A 427;VAL A 477;TYR A 242;ARG A 459","None;None;None;SO4 A 601 (-3.6A)","1.04A","4r7iA-5cwaA:undetectable","4r7iA-5cwaA:20.99"],["4XDT_A_ACTA407_0","FAD:PROTEIN FMN TRANSFERASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",3,"ASP A 115;GLY A 450;ASP A 447","None","0.62A","4xdtA-5cwaA:0.5","4xdtA-5cwaA:22.10"],["4XP1_A_LDPA708_1","DOPAMINE TRANSPORTER, ISOFORM B","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"ALA A 461;VAL A 496;SER A 305;SER A 304;GLY A 303","None","1.12A","4xp1A-5cwaA:undetectable","4xp1A-5cwaA:22.98"],["4YDQ_A_HFGA802_1","PROLINE--TRNA LIGASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"THR A 415;GLU A 307;THR A 325;HIS A 388","None;0GA A 604 ( 4.5A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","1.47A","4ydqA-5cwaA:undetectable","4ydqA-5cwaA:19.04"],["4Z90_F_4LEF401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"LEU A 159;THR A 107;LEU A 108;LEU A 104","None","0.78A","4z90F-5cwaA:undetectable;4z90G-5cwaA:undetectable;4z90H-5cwaA:undetectable;4z90I-5cwaA:undetectable;4z90J-5cwaA:undetectable","4z90F-5cwaA:21.07;4z90G-5cwaA:21.07;4z90H-5cwaA:21.07;4z90I-5cwaA:21.07;4z90J-5cwaA:21.07"],["5D0Y_A_FOLA201_0","CONSERVED HYPOTHETICAL MEMBRANE PROTEIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"GLY A  70;ASP A 447;PHE A 448;ASN A 180;VAL A 182","None","1.26A","5d0yA-5cwaA:undetectable","5d0yA-5cwaA:16.70"],["5ECK_A_ILEA601_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"ALA A 162;THR A 163;VAL A 165;VAL A  23","None","0.95A","5eckA-5cwaA:undetectable","5eckA-5cwaA:21.87"],["5ECK_D_ILED601_0","JASMONIC ACID-AMIDO SYNTHETASE JAR1","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"ALA A 162;THR A 163;VAL A 165;VAL A  23","None","0.87A","5eckD-5cwaA:undetectable","5eckD-5cwaA:21.87"],["5F9Z_A_HFGA702_1","AMINOACYL-TRNA SYNTHETASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"THR A 415;GLU A 307;THR A 325;HIS A 388","None;0GA A 604 ( 4.5A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","1.43A","5f9zA-5cwaA:undetectable","5f9zA-5cwaA:19.61"],["5F9Z_B_HFGB703_1","AMINOACYL-TRNA SYNTHETASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",4,"THR A 415;GLU A 307;THR A 325;HIS A 388","None;0GA A 604 ( 4.5A);0GA A 604 ( 4.6A);0GA A 604 ( 4.3A)","1.43A","5f9zB-5cwaA:undetectable","5f9zB-5cwaA:19.61"],["5O96_B_SAMB501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",6,"ARG A 201;ILE A  69;GLY A  70;GLY A  72;LEU A 209;LEU A 177","None","1.21A","5o96A-5cwaA:undetectable;5o96B-5cwaA:undetectable","5o96A-5cwaA:20.04;5o96B-5cwaA:20.04"],["5T2Z_B_017B201_1","PROTEASE;PROTEASE","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"LEU A 125;ASP A 447;GLY A 450;ALA A 449;ASP A 115","None","1.08A","5t2zA-5cwaA:undetectable","5t2zA-5cwaA:12.18"],["6AWO_A_SREA701_1","SODIUM-DEPENDENT SEROTONIN TRANSPORTER","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"ALA A 457;ILE A 456;GLY A 474;SER A 417;GLY A 440","None;None;0GA A 604 ( 4.4A);None;None","1.29A","6awoA-5cwaA:undetectable","6awoA-5cwaA:20.79"],["6AWQ_A_SREA701_1","SODIUM-DEPENDENT SEROTONIN TRANSPORTER","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"ALA A 457;ILE A 456;GLY A 474;SER A 417;GLY A 440","None;None;0GA A 604 ( 4.4A);None;None","1.29A","6awqA-5cwaA:undetectable","6awqA-5cwaA:20.79"],["6D8F_A_ACTA803_0","UNCHARACTERIZED PROTEIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",3,"GLU A 339;LEU A 342;ARG A 349","None","0.77A","6d8fA-5cwaA:undetectable","6d8fA-5cwaA:22.70"],["6F6N_A_SREA508_1","ENVELOPE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1;ENVELOPE GLYCOPROTEIN","5cwa","ANTHRANILATE SYNTHASE COMPONENT 1","Mycobacterium tuberculosis",5,"ARG A  22;VAL A 182;LEU A 111;LEU A  77;LEU A 161","None","1.00A","6f6nA-5cwaA:undetectable;6f6nB-5cwaA:undetectable","6f6nA-5cwaA:10.83;6f6nB-5cwaA:9.09"]]